300 related articles for article (PubMed ID: 24703206)
1. Beta-blockers in older patients with heart failure and preserved ejection fraction: class, dosage, and outcomes.
Patel K; Fonarow GC; Ekundayo OJ; Aban IB; Kilgore ML; Love TE; Kitzman DW; Gheorghiade M; Allman RM; Ahmed A
Int J Cardiol; 2014 May; 173(3):393-401. PubMed ID: 24703206
[TBL] [Abstract][Full Text] [Related]
2. Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate.
Lam PH; Gupta N; Dooley DJ; Singh S; Deedwania P; Zile MR; Bhatt DL; Morgan CJ; Pitt B; Fonarow GC; Ahmed A
Am J Med; 2018 Dec; 131(12):1473-1481. PubMed ID: 30076815
[TBL] [Abstract][Full Text] [Related]
3. Heart failure medication dosage and survival in women and men seen at outpatient clinics.
Bots SH; Onland-Moret NC; Tulevski II; van der Harst P; Cramer MJM; Asselbergs FW; Somsen GA; den Ruijter HM
Heart; 2021 Nov; 107(21):1748-1755. PubMed ID: 34261736
[TBL] [Abstract][Full Text] [Related]
4. Association Between β-Blocker Use and Mortality/Morbidity in Patients With Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction and Advanced Chronic Kidney Disease.
Fu EL; Uijl A; Dekker FW; Lund LH; Savarese G; Carrero JJ
Circ Heart Fail; 2020 Nov; 13(11):e007180. PubMed ID: 33070637
[TBL] [Abstract][Full Text] [Related]
5. Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions.
Verbrugge FH; Duchenne J; Bertrand PB; Dupont M; Tang WH; Mullens W
Am J Cardiol; 2013 Dec; 112(12):1913-20. PubMed ID: 24286620
[TBL] [Abstract][Full Text] [Related]
6. Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction.
Lund LH; Benson L; Dahlström U; Edner M; Friberg L
JAMA; 2014 Nov; 312(19):2008-18. PubMed ID: 25399276
[TBL] [Abstract][Full Text] [Related]
7. Guideline-Directed Medical Therapy in Newly Diagnosed Heart Failure With Reduced Ejection Fraction in the Community.
Dunlay SM; Killian JM; Roger VL; Schulte PJ; Blecker SB; Savitz ST; Redfield MM
J Card Fail; 2022 Oct; 28(10):1500-1508. PubMed ID: 35902033
[TBL] [Abstract][Full Text] [Related]
8. Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial.
Edelmann F; Musial-Bright L; Gelbrich G; Trippel T; Radenovic S; Wachter R; Inkrot S; Loncar G; Tahirovic E; Celic V; Veskovic J; Zdravkovic M; Lainscak M; Apostolović S; Neskovic AN; Pieske B; Düngen HD;
JACC Heart Fail; 2016 Feb; 4(2):140-149. PubMed ID: 26682793
[TBL] [Abstract][Full Text] [Related]
9. Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction.
Park CS; Park JJ; Mebazaa A; Oh IY; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
J Am Heart Assoc; 2019 Mar; 8(6):e011077. PubMed ID: 30845873
[TBL] [Abstract][Full Text] [Related]
10. β-Blockers and 1-Year Postdischarge Mortality for Heart Failure and Reduced Ejection Fraction and Slow Discharge Heart Rate.
Park JJ; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
J Am Heart Assoc; 2019 Feb; 8(4):e011121. PubMed ID: 30755071
[TBL] [Abstract][Full Text] [Related]
11. Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
Malik A; Masson R; Singh S; Wu WC; Packer M; Pitt B; Waagstein F; Morgan CJ; Allman RM; Fonarow GC; Ahmed A
J Am Coll Cardiol; 2019 Aug; 74(5):617-627. PubMed ID: 31370952
[TBL] [Abstract][Full Text] [Related]
12. Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation.
Ahn MS; Yoo BS; Son JW; Yu MH; Kang DR; Lee HY; Jeon ES; Kim JJ; Chae SC; Baek SH; Kang SM; Choi DJ; Kim KH; Cho MC; Kim SY
J Korean Med Sci; 2020 Aug; 35(33):e278. PubMed ID: 32830467
[TBL] [Abstract][Full Text] [Related]
13. Response to beta-blockers and natriuretic peptide level in acute heart failure: analysis of data from the Korean acute heart failure registry.
Park CS; Park JJ; Mebazaa A; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
Clin Res Cardiol; 2021 Sep; 110(9):1392-1403. PubMed ID: 32588127
[TBL] [Abstract][Full Text] [Related]
14. Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum.
Lund LH; Claggett B; Liu J; Lam CS; Jhund PS; Rosano GM; Swedberg K; Yusuf S; Granger CB; Pfeffer MA; McMurray JJV; Solomon SD
Eur J Heart Fail; 2018 Aug; 20(8):1230-1239. PubMed ID: 29431256
[TBL] [Abstract][Full Text] [Related]
15. Beta-blocker therapy in heart failure with preserved ejection fraction (B-HFpEF): A systematic review and meta-analysis.
Kaddoura R; Madurasinghe V; Chapra A; Abushanab D; Al-Badriyeh D; Patel A
Curr Probl Cardiol; 2024 Mar; 49(3):102376. PubMed ID: 38184132
[TBL] [Abstract][Full Text] [Related]
16. Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.
Lam PH; Dooley DJ; Deedwania P; Singh SN; Bhatt DL; Morgan CJ; Butler J; Mohammed SF; Wu WC; Panjrath G; Zile MR; White M; Arundel C; Love TE; Blackman MR; Allman RM; Aronow WS; Anker SD; Fonarow GC; Ahmed A
J Am Coll Cardiol; 2017 Oct; 70(15):1861-1871. PubMed ID: 28982499
[TBL] [Abstract][Full Text] [Related]
17. Low Utilization of Beta-Blockers Among Medicare Beneficiaries Hospitalized for Heart Failure With Reduced Ejection Fraction.
Loop MS; van Dyke MK; Chen L; Safford MM; Kilgore ML; Brown TM; Durant RW; Levitan EB
J Card Fail; 2019 May; 25(5):343-351. PubMed ID: 30339796
[TBL] [Abstract][Full Text] [Related]
18. Digoxin use and lower risk of 30-day all-cause readmission in older patients with heart failure and reduced ejection fraction receiving β-blockers.
Lam PH; Bhyan P; Arundel C; Dooley DJ; Sheriff HM; Mohammed SF; Fonarow GC; Morgan CJ; Aronow WS; Allman RM; Waagstein F; Ahmed A
Clin Cardiol; 2018 Mar; 41(3):406-412. PubMed ID: 29569405
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of heart failure with preserved ejection fraction treated with β-blockers: A propensity matched study in the community.
Ruiz G; Andrey JL; Puerto JL; Escobar MA; Romero SP; Aranda R; Pedrosa MJ; Gomez F
Int J Cardiol; 2016 Nov; 222():594-602. PubMed ID: 27513657
[TBL] [Abstract][Full Text] [Related]
20. Beta-Blocker Use and Heart Failure Outcomes in Mildly Reduced and Preserved Ejection Fraction.
Arnold SV; Silverman DN; Gosch K; Nassif ME; Infeld M; Litwin S; Meyer M; Fendler TJ
JACC Heart Fail; 2023 Aug; 11(8 Pt 1):893-900. PubMed ID: 37140513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
